HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved therapy of myotonia with the lidocaine derivative tocainide.

Abstract
The antimyotonic effect of the antiarrhythmic drug tocainide was tested in 14 patients. With 1200 to 1600 mg/d all patients reported good improvement. This was substantiated by objective tests. Only four patients noticed minor side effects.
AuthorsR Rüdel, R Dengler, K Ricker, A Haass, W Emser
JournalJournal of neurology (J Neurol) Vol. 222 Issue 4 Pg. 275-8 ( 1980) ISSN: 0340-5354 [Print] Germany
PMID6154787 (Publication Type: Journal Article)
Chemical References
  • Anilides
  • Anti-Arrhythmia Agents
  • Tocainide
Topics
  • Adolescent
  • Adult
  • Aged
  • Anilides (adverse effects, therapeutic use)
  • Anti-Arrhythmia Agents (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myotonia (drug therapy)
  • Tocainide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: